Drugs / HepBQuin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03899142 | Mar → Jul 2019 | — | Prothya Biosolutions | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HepBQuin | “HepBQuin will serve as model for all other Quin products.” NCT03899142 ↗ |
| Modality | Protein / enzyme biologic | “human hepatitis B immunoglobulin” NCT03899142 ↗ |
| Route | Intramuscular | “intramuscular administration” NCT03899142 ↗ |